Corriente Advisors LLC 13D/13G Filings for Cardiff Oncology, Inc. (CRDF)

Corriente Advisors LLC 13D and 13G filings for Cardiff Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
4:04 pm
Sale		 2021-12-31 13G Cardiff Oncology, Inc.
CRDF		 Corriente Advisors LLC 0
0.000%		 -2,000,000decrease
(Position Closed)		 Filing
2021-02-16
06:18 am
Purchase		 2020-12-31 13G Cardiff Oncology, Inc.
CRDF		 Corriente Advisors LLC 2,000,000
5.660%		 2,000,000increase
(New Position)		 Filing